Candel Therapeutics CADL
NASDAQ CADL
$8.03 -0.35 (-4.18%)
At close: Oct 23, 2026 · 4:00 PM EDT

Candel Therapeutics (CADL) Amortization of Deferred Charges (2022 - 2025)

Updated

Analysis

Candel Therapeutics (CADL) Amortization of Deferred Charges (2022 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn
10 Candel Therapeutics 596.02 Mn 87.07 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 263,000.00
Sep 30, 2025 21,000.00
Jun 30, 2025 32,000.00
Mar 31, 2025 44,000.00
Dec 31, 2024 52,000.00
Sep 30, 2024 62,000.00
Jun 30, 2024 73,000.00
Mar 31, 2024 83,000.00
Dec 31, 2023 86,000.00
Sep 30, 2023 83,000.00
Jun 30, 2023 79,000.00
Mar 31, 2023 75,000.00
Dec 31, 2022 80,000.00
Sep 30, 2022 96,000.00
Jun 30, 2022 83,000.00
Mar 31, 2022 32,000.00
API Access

Candel Therapeutics Amortization of Deferred Charges API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=amortization-of-deferred-charges&ticker=CADL&period=max&api_key=YOUR_API_KEY